Adjuvant advises disease philanthropies and foundations supporting medical research on management of their grant-making and investment activities.
This work includes due diligence and project management of specific funds dedicated to support early-stage and translational programs. Adjuvant
oversees the development of the contracts with the companies or research institutions and also provides follow-on support as these grantees or
recipients of funds move to the next stage of their development. This work has included the management of the first-ever partnership fund between
a major disease philanthropy and a pharmaceutical company to fund a range of promising early-stage programs. Adjuvant also advises its corporate
clients on access to philanthropic funding sources.